Rat somatic genome editing enables ER+ breast cancer modeling
Proceedings of the National Academy of Sciences · 30.06.2026 · 123 (26)
DOI: 10.1073/pnas.2529653123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 22.06.2026. Verfasst von Wen Bu und 22 weiteren Autor:innen. Beteiligte Einrichtung: Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030. Hauptthemen laut MEDLINE: Gene Editing, Receptors, Estrogen, Breast Neoplasms. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, HHS | NIH | Center for Scientific Review (CSR), U.S. Department of Defense (DOD).
Abstract (Originalsprache)
Genetically engineered mouse models have advanced cancer research, but they fail to mimic some human diseases. Rats offer a powerful alternative for modeling human cancers that are inadequately represented in mice, yet their use has been constrained by technical barriers to genome editing. Here, we report somatic genome editing in rats and apply this approach to model estrogen receptor (ER)-positive breast cancer, which accounts for approximately 70% of human cases but remains poorly represented in mice. The resulting rat tumors reproduce hallmarks of human ER+ breast cancer, including ductal histology, hormone responsiveness, and immune microenvironment features. By contrast, identical genetic alterations in mice failed to yield ER+ tumors, underscoring critical species differences in tumorigenesis. Together, this work establishes a versatile platform for the rapid generation of clinically relevant rat tumor models, opening avenues to study tumor biology, therapeutic response, and immune interactions in cancer subtypes previously inaccessible to experimental modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030.
- Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030.
- Department of Pathology, Baylor College of Medicine, Houston, TX 77030.
- Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
ORCID-Profile: Wen Bu, Tobie D Lee, Ruixin Xu, Lillian He, Alexandria Z Bu, Chandandeep Nagi, Jing Wang, Susan G Hilsenbeck, Chonghui Cheng, Shixia Huang, Jianming Xu, C Kent Osborne, Eric C Chang, Xiang H-F Zhang, Yi Li
Förderung
- NIH HHS
- HHS | NIH | Center for Scientific Review (CSR)
- U.S. Department of Defense (DOD)
Zitieren
APA
Bu, W., Lee, T. D., Anurag, M., Dou, Y., Ding, Y., Shi, Z., Xu, R., He, L., Bu, A. Z., Nagi, C., Gutierrez, C., Wang, J., Hilsenbeck, S. G., Cheng, C., Zhang, B., Huang, S., Xu, J., Osborne, C. K., Sreekumar, A., …, & Li, Y. (2026). Rat somatic genome editing enables ER+ breast cancer modeling. Proceedings of the National Academy of Sciences, 123(26). https://doi.org/10.1073/pnas.2529653123
Vancouver
Bu W, Lee TD, Anurag M, Dou Y, Ding Y, Shi Z, et al. Rat somatic genome editing enables ER+ breast cancer modeling. Proceedings of the National Academy of Sciences. 2026;123(26). doi:10.1073/pnas.2529653123
BibTeX
@article{Bu2026,
author = {Bu, Wen and Lee, Tobie D and Anurag, Meenakshi and Dou, Yongchao and Ding, Yunfeng and Shi, Zhiao and Xu, Ruixin and He, Lillian and Bu, Alexandria Z and Nagi, Chandandeep and Gutierrez, Carolina and Wang, Jing and Hilsenbeck, Susan G and Cheng, Chonghui and Zhang, Bing and Huang, Shixia and Xu, Jianming and Osborne, C Kent and Sreekumar, Arun and Chang, Eric C and Creighton, Chad J and Zhang, Xiang H-F and Li, Yi},
title = {Rat somatic genome editing enables ER+ breast cancer modeling},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {26},
doi = {10.1073/pnas.2529653123}
}
EUVIMED